Loading clinical trials...

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML | Clinical Trials | Clareo Health

Not Yet RecruitingPhase 4

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

A Multicenter, Prospective, Randomized Controlled Study Comparing the Efficacy and Safety of CLAG(Cladribine, Cytarabine and G-CSF) Combined With Venetoclax and CLAG in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

NCT06763666•Nanfang Hospital, Southern Medical University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Relapsed/Refractory AML

Interventions

Cladribine

Cytarabine

+2 more

Locations

China

Locations (1)

Department of Hematology,Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China

Key Dates

Start Date

February 1, 2025

Primary Completion Date

June 1, 2025

Completion Date

December 1, 2025

Last Updated

January 8, 2025

Related Studies

Active Not RecruitingPhase 1/2

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

NCT05428969

Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia+2 more

View study

UNKNOWNPhase 2/3

CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001)

NCT03631576

Relapsed/Refractory AML

View study

Contacts

Guopan Yu

CONTACT

+8615876559968 yugpp@163.com

Guopan Yu

CONTACT

Sponsors

Lead Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou No.12 People's Hospital
Guangzhou Panyu Central Hospital
Guangzhou General Hospital of Guangzhou Military Command
Guangzhou First People's Hospital
Foresea Life Insurance Guangzhou General Hospital
Guangdong Second Provincial General Hospital
Jiangmen Central Hospital
Shantou Central Hospital
Maoming People's Hospital
First Affiliated Hospital of Guangxi Medical University
Hainan General Hospital
Dongguan People's Hospital
Tungwah Hospital of Sun Yat-Sen University
Shenzhen Hospital of Southern Medical University
Central People's Hospital of Zhanjiang
ZhuHai Hospital
Shenzhen Second People's Hospital
Zhongshan People's Hospital, Guangdong, China
LiuZhou People's Hospital
First People's Hospital of Foshan
Southern Medical University, China
Affiliated Hospital of Guangdong Medical University
Guilin Medical University, China
Yuebei People's Hospital
Huizhou Municipal Central Hospital
Second Affiliated Hospital of Guangzhou Medical University
Peking University Shenzhen Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions